The global antimicrobial therapeutics market size was valued at USD 216.8 billion in 2024, driven by the rising prevalence of bacterial infections across the globe. The market is expected to grow at a CAGR of 4.8% during the forecast period of 2025-2034, with the values likely to rise from USD 227.2 billion in 2025 to USD 330.6 billion by 2034.
Base Year
Historical Year
Forecast Year
Antimicrobial therapeutics involve a set of treatments for infections or diseases caused by bacteria, fungus, viruses, or parasites. They work by either killing the microorganisms or inhibiting its growth. It includes a range of drugs such as antibiotics, antivirals, antifungals, and antiparasitic. The development and application of antimicrobial medications can be considered crucial in treating infectious diseases, preventing the spread of infections, and saving lives.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Antimicrobial therapeutics include treatments against several microorganisms such as bacteria, viruses, fungi, and parasites. The antimicrobial therapeutics market growth is fuelled by the development and approval of drugs. In March 2023, the FDA approved Cidara Therapeutics Inc's drug, rezafungin (branded as Rezzayo), to treat a group of severe fungal infections, commonly faced by hospitalized patients.
In November 2023, the FDA also approved a new beta-lactam/beta-lactamase inhibitor antibiotic, sulbactam-durlobactam for patients with carbapenem-resistant Acinetobacter infection. This group of bacteria has been responsible for causing blood infections, pneumonia and urinary tract infections. Apart from pharmacological approaches, researchers have been working towards developing combination therapies to bring effective and rapid solutions for the patients.
Antimicrobial resistance is turning out to be a global health concern and is expected to surpass 10 million deaths globally by 2050. As a result, the antimicrobial therapeutics market value is driven by strong emphasis on battling anti-microbial resistance. To combat the rising burden, companies like Glox Therapeutics (a Scottish company) are working towards developing precision antibiotics with the help of protein bacteriocins that exhibit targeted specificity for gram negative pathogens. With the ongoing developments and extensive research, the market is projected to grow significantly in the forecast period.
“Antimicrobial Therapeutics Market Report and Forecast 2024-2032” offers a detailed analysis of the market based on the following segments:
Market Breakup by Drug Class
Market Breakup by Route of Administration
Market Breakup by Indications
Market Breakup by Spectrum of Activity
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The United States, with a prominent research and development infrastructure and key healthcare companies, has led the market antimicrobial therapeutics market share in recent years. This trend is expected to continue with rising privatization of the medical ecosystem. The acquisition of smaller research companies by pharmaceutical giants is fostering market growth. In addition, the establishment of new and high-end research centers in the region is also expected to improve the quality and frequency of drug development and approvals in the region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
With several influential government programs, the European region is another key player in the market. A program called PACE (Pathways to Antimicrobial Clinical Efficacy) set up under the collaboration of Innovate UK and LifeArc & Medicines Discovery Catapult is offering a GBP 10 million grant funding for the early phase drug discovery and diagnostic projects. Such initiatives are expected to add to the market growth significantly.
The Asia Pacific region is also projected to witness expediated antimicrobial therapeutics market growth in the forecast period, owing to rising investments with an increased emphasis on improving the medical infrastructure. The region is experiencing a rising number of drug approvals which are expected to impact the market positively in upcoming years.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 216.8 billion in 2024, driven by the rising incidence of microorganism associated infectious diseases across the globe.
The market is anticipated to grow at a CAGR of 4.8% during the forecast period of 2025-2034, likely to reach a market value of USD 330.6 billion by 2034.
The high market demand is driven by the technological advancements, growing research, and development projects for manufacturing PoC products, along with the existence of a strong pipeline of drug approvals.
The current market trend is based on the tackling the increasing antimicrobial resistance among the masses. Scotland based Glox Therapeutics is working towards developing precision antibiotics with the help of protein bacteriocins.
The routes of administration can be divided into oral, topical, and parenteral.
Based on drug class, it is divided into antibacterial, antiviral, antifungal and antiparasitic therapeutics.
These therapeutics are used for respiratory infections, urinary tract infections, skin infections, sexually transmitted infections, and gastrointestinal infections, among others.
The activity spectrum can be divided into broad spectrum and narrow spectrum.
Major end users include homecare and research institutes, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are F. Hoffmann-La Roche Ltd., Mylan N.V., Sanofi, Pfizer Inc., GlaxoSmithKline plc (GSK), Novartis AG, Bayer AG, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Fresenius Kabi AG, Teva Pharmaceutical Industries Ltd., AstraZeneca plc., and Akorn Incorporated.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Route of Administration |
|
| Breakup by Indications |
|
| Breakup by Spectrum of Activity |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
USD 2,969
USD 2,499
tax inclusive*
Single User License
One User
USD 5,499
USD 4,699
tax inclusive*
Five User License
Five Users
USD 6,599
USD 5,599
tax inclusive*
Corporate License
Unlimited Users
USD 7,699
USD 6,599
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share